La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Anixa Biosciences a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Anixa Biosciences..

Anixa Biosciences (NASDAQ:ANIX) Azioni, Catena delle Opzioni

ANIXA BIOSCIENCES INC

Anixa Biosciences

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Anixa Biosciences Inc

Morgan Stanley analyst Ravi Shanker maintains Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) with a Equal-Weight and lowers the price target from $220 to $215.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Union Pacific, Lowers Price Target to $215

UBS analyst Thomas Wadewitz maintains United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) with a Buy and lowers the price target from $105 to $103.

UBS Maintains Buy on United Airlines Holdings, Lowers Price Target to $103

Morgan Stanley analyst Bob Huang downgrades Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) from Overweight to Equal-Weight and lowers the price target from $330 to $290.

Downgrades

Morgan Stanley Downgrades Progressive to Equal-Weight, Lowers Price Target to $290

Groq, a U.S.-based startup specializing in AI chips, has launched its first European data center in Helsinki, Finland as part of the company's international expansion and goal to meet the rising demand for AI <a href="https://www.benzinga.com/news/financing/25/05/45297876/after-spacex-cathie-wood-bets-big-on-elon-musks-xai">services across Europe. </a>
The Details: Groq's new Helsinki location was developed in partnership with Equinix, a major global data center provider.
Read Next:<a href="https://www.benzinga.com/analyst-stock-ratings/upgrades/25/07/46245952/metas-growth-sizzles-but-wait-for-a-pullback-before-buying-in?utm_source=articleShare"> Meta&#8217;s Growth Sizzles, But Wait For A Pullback Before Buying In</a>
Finland was chosen due to factors that make it ideal for large-scale data centers, including reliable energy infrastructure, abundance of renewable energy and a cool climate. according to <a href="https://www.cnbc.com/2025/07/07/ai-chip-startup-groq-expands-with-first-european-data-center.html">CNBC</a>. 
The decision to build the Helsinki data center was made just four weeks before its launch, highlighting Groq's ability to move quickly. The company expects to start serving customers almost immediately.&nbsp;
Why It Matters: Groq, which is valued at $2.8 billion and backed by investors such as Samsung and Cisco, is positioning itself as a challenger to established players like NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) in the AI inference market.&nbsp;
Groq specializes in inferencing, which is the process of running live data through pre-trained AI models. Inferencing is less demanding than training new AI models—a process that usually relies on Nvidia's GPUs due to its high computational requirements.
Unlike other competitors, Groq's chips do not rely on expensive, hard-to-source components like high-bandwidth memory. 
Most of its supply chain is based in North America, making Groq less vulnerable to global supply disruptions and tariffs. 
Groq already operates data centers in the United States, Canada and Saudi Arabia. The new Helsinki center strengthens its presence in Europe and supports its goal of delivering fast, affordable AI inference capabilities worldwide.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46236537/openai-says-tokens-are-not-equity-no-partnership-with-robinhood-musk-says-ai-companys-equity-is-fake?utm_source=articleShare">OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company&#8217;s Equity &#8216;Is Fake&#8217;</a></li>
</ul>
Image: Shutterstock

Global

Movers

Tech

Trading Ideas

NVDA

Nvidia's AI Chip Rival Groq Launches First European Data Center

UBS analyst Thomas Wadewitz maintains Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) with a Buy and lowers the price target from $66 to $63.

UBS Maintains Buy on Delta Air Lines, Lowers Price Target to $63

Morgan Stanley analyst Toni Kaplan maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Overweight and raises the price target from $587 to $595.

SPGI

Morgan Stanley Maintains Overweight on S&P Global, Raises Price Target to $595

Morgan Stanley analyst Ravi Shanker maintains RXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RXO#NYSE">RXO</a>) with a Equal-Weight and lowers the price target from $23 to $21.

Morgan Stanley Maintains Equal-Weight on RXO, Lowers Price Target to $21

UBS analyst Timothy Arcuri maintains Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) with a Buy and lowers the price target from $285 to $280.

UBS Maintains Buy on Analog Devices, Lowers Price Target to $280

Macro Economic Events

Politics

Economics

General

Reuters Cites EU's Von Der Leyen Saying Europe Must Show Strength In Trade Negotiations With U.S.

Morgan Stanley analyst Ravi Shanker maintains JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) with a Equal-Weight and lowers the price target from $160 to $155.

JBHT

Morgan Stanley Maintains Equal-Weight on JB Hunt Transport Servs, Lowers Price Target to $155

Google has signed a groundbreaking agreement with Commonwealth Fusion Systems, a nuclear startup backed by <a href="https://www.benzinga.com/news/25/05/45184302/bill-gates-daughter-launches-phia-a-850k-ai-powered-fashion-app-with-backing-from-kris-jenner-and-desiree-gruber">Bill Gates</a>, in one of the first commercial deals for fusion energy. The tech giant plans to purchase 200 megawatts of power from CFS's upcoming affordable, robust, and compact fusion plant in Chesterfield County, Virginia, enough to supply roughly 75,000 homes,<a href="https://www.wsj.com/articles/google-signs-deal-to-buy-fusion-energy-from-bill-gates-backed-nuclear-startup-9017672b"> The Wall Street Journal</a> reports.
According to the Journal, this deal represents a defining moment for the fusion energy sector. Fusion, the same reaction that powers the sun, has never been used commercially since most <a href="https://www.benzinga.com/markets/commodities/25/06/46068183/new-york-to-construct-first-major-us-nuclear-plant-in-15-years-amid-trumps-push-to-fast-track-atomic-energy">nuclear plants</a> today rely on fission, a technology that splits atoms to produce energy. Fusion, by contrast, generates energy by fusing atoms, promising a nearly limitless supply of power with minimal radioactive waste.
Don't Miss:
<ul class="wp-block-list">
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
<li>GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a></li>
</ul>
<h2 class="wp-block-heading">A First-Of-Its-Kind Deal Anchored by a Billionaire-Backed Vision</h2>
The new agreement between Google and CFS marks the largest direct fusion energy deal to date. CFS spun out of the Massachusetts Institute of Technology and has raised over $2 billion so far. While CFS did not disclose the exact financial terms of the Google deal, it confirmed to the Journal that the agreement is valued in the multibillion-dollar range.
Bill Gates's Breakthrough Energy Ventures is a key backer of the project, the Journal says. With this agreement, Google becomes one of the first major tech companies to commit to purchasing fusion-generated power. In 2023, Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) signed a <a href="https://www.helionenergy.com/articles/helion-announces-worlds-first-fusion-ppa-with-microsoft/">deal</a> with Helion Energy for 50 megawatts of fusion power, but Google's deal is four times that size and includes the option to purchase additional energy from future plants.
CFS Chief Executive Bob Mumgaard believes this collaboration signals to the global market that fusion is moving from theory to application. "This puts fusion into this category of ‘this is not like someday future stuff.' This is concrete," he told The Journal.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
<h2 class="wp-block-heading">Google's Race to Net Zero Fuels Investment in Fusion</h2>
The deal comes just days after Google released its latest sustainability report, which showed a significant increase in overall emissions, even as the company cut emissions at its data centers. According to the Journal, Google purchased 8 gigawatts of clean energy in 2024 but still saw total emissions grow by 11%, reaching 11.5 million metric tons of carbon dioxide equivalent.
Michael Terrell, Google's head of advanced energy, emphasized the company's commitment to pursuing clean solutions amid rising energy demands. "By entering into this agreement with CFS, we hope to help prove out and scale a promising pathway toward commercial fusion power," he told the Journal.
According to The Journal, Google views fusion as a transformative technology with the potential to meet growing energy demand, especially as existing power systems struggle with rising costs, outdated grids, and complex regulations.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation.&nbsp;</a>
The ARC fusion plant in Virginia is expected to be operational by the 2030s. If successful, The Journal says it could transform the energy landscape. With half the plant's output already committed to Google, CFS believes the deal could attract more buyers as fusion moves from theory to reality.
With billions invested and leading tech companies entering long-term contracts, the race to bring fusion to the grid is officially underway.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

MSFT

Google Wants To Hit Net Zero By 2030 — So It Signed A Massive Deal With A Bill Gates-Backed Startup That's Still Years Away From Making Energy

UBS analyst Timothy Arcuri maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Buy and raises the price target from $215 to $245.

UBS Maintains Buy on Texas Instruments, Raises Price Target to $245

Morgan Stanley analyst Keith Weiss maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Overweight and raises the price target from $785 to $900.

INTU

Morgan Stanley Maintains Overweight on Intuit, Raises Price Target to $900

<a href="https://techcrunch.com/2025/07/07/threads-is-nearing-xs-daily-app-users-new-data-shows/">https://techcrunch.com/2025/07/07/threads-is-nearing-xs-daily-app-users-new-data-shows/</a>
&nbsp;

'Threads is nearing X's daily app users, new data shows' - TechCrunch

UBS analyst Pradeep Ramani maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral and raises the price target from $45 to $55.

UBS Maintains Neutral on ON Semiconductor, Raises Price Target to $55

Morgan Stanley analyst James Faucette initiates coverage on Chime Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) with a Overweight rating and announces Price Target of $39.

Initiation

CHYM

Morgan Stanley Initiates Coverage On Chime Financial with Overweight Rating, Announces Price Target of $39

In a first for the crypto ETF market, REX-Osprey, a joint venture between REX Shares and Osprey Funds, launched the REX-Osprey Solana + Staking ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/SSK#BATS">SSK</a>), the first <a href="https://www.benzinga.com/etfs">U.S.-listed ETF</a> to provide both spot Solana (SOL/USD) exposure and staking returns in a typical brokerage account.
This product sets a precedent among ETFs by combining conventional investment vehicle designs with blockchain-native income streams. In contrast with derivatives-based crypto products, SSK seeks pure-play SOL exposure without futures-based contango drag and introduces a twist: staking rewards, which presently return 7.3%, are rebated to investors, with no take by the fund sponsors.
Also Read: <a href="https://www.benzinga.com/markets/bonds/25/07/46252249/vanguard-plans-low-cost-junk-bond-etf-as-demand-for-high-yield-grows">Vanguard Plans Low-Cost Junk Bond ETF As Demand For High-Yield Grows</a>
<h2 class="wp-block-heading">How It Works</h2>
The ETF will allocate its assets as follows:
<ul class="wp-block-list">
<li>Majority in directly staked SOL, held securely and earning rewards from Solana&#8217;s native blockchain</li>
<li>Up to 40% in exchange-traded products that themselves stake SOL</li>
<li>A slice in liquid staking tokens such as JitoSOL</li>
</ul>
This framework not only provides investors with direct exposure to the Solana price action, but also to the passive income opportunity of staking without having to use a personal wallet or directly interact with the blockchain.
<h2 class="wp-block-heading">TradFi Meets DeFi</h2>
SSK differentiates itself in a crowded space of crypto asset ETFs by combining the convenience and transparency of traditional ETFs with actual involvement in blockchain economics. It&#8217;s targeted at retail investors and institutions looking for yield on their crypto exposure in a more familiar package.
Although innovative, SSK is not riskless. As the issuer explains, the fund does not signify ownership of SOL and involves substantial market risks, including the possibility of loss of principal.
Nevertheless, with this introduction, REX-Osprey has risked more than crypto; it has carved out a first-mover advantage in an ETF space that&#8217;s rapidly evolving.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46274956/xrp-stuck-below-2-30-why-is-it-not-moving">XRP Stuck Below $2.30: Why Is It Not Moving?</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New ETFs

ETFs

This Solana-Focused ETF By REX-Osprey Offers A New Way To Earn from Crypto

UBS analyst Pradeep Ramani maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and raises the price target from $65 to $85.

MCHP

UBS Maintains Buy on Microchip Technology, Raises Price Target to $85

Morgan Stanley analyst Ravi Shanker maintains Allegiant Travel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGT#NASDAQ">ALGT</a>) with a Equal-Weight and lowers the price target from $85 to $83.

ALGT

Morgan Stanley Maintains Equal-Weight on Allegiant Travel, Lowers Price Target to $83

UBS analyst Thomas Wadewitz maintains Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) with a Neutral and raises the price target from $27 to $34.

UBS Maintains Neutral on Southwest Airlines, Raises Price Target to $34

Press Releases

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Comments

Anixa Biosciences

Anixa Biosciences (ANIX) Opzioni

Anixa Biosciences (NASDAQ:ANIX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO